Close X
Monday, November 11, 2024
ADVT 
Health

UVic Develops Less-bloody Blood Test That Is Already In Use At Mayo Clinic

Darpan News Desk The Canadian Press, 17 Nov, 2015 10:57 AM
    VICTORIA — Forget the long, sharp needles and vials of blood taken to check for cancers, diabetes and heart problems — researchers at the University of Victoria have developed a new test requiring only a single drop.
     
    Retired University of Victoria biochemist Terry Pearson said in an interview that his researchers have developed a less invasive, cheaper and more personalized method of blood testing that relies on a pin prick and a single drop of blood.
     
    The blood test, not yet available in Canada, is already being used at the Mayo Clinic in the United States to test for thyroid cancer, he said.
     
    "It works, and it works well," said Pearson. "The technology is fabulous, actually. This is big. Our idea is to make diagnostic medicine better by a quantum leap by being able to test for multiple proteins at once, inexpensively."
     
    During the test, the drop of blood is collected on a filtered paper and taken to a laboratory, he said.
     
    "We can do up to 25 tests on the one drop of blood," Pearson said, noting markers can be found for cardiovascular diseases, diabetes and signs of prostate and ovarian cancers.
     
    "We think it's going to really, truly revolutionize diagnostic medicine."
     
    The technology was developed at UVic over 13 years and in partnership with U.S. researcher Leigh Anderson, based in Washington, D.C.
     
    Anderson founded in 2006 the non-profit Plasma Proteome Institute, which uses new technology to analyze blood and diagnose diseases.
     
    Pearson said he and Anderson have been friends for more than 40 years and have worked together on blood-test research.
     
    "Leigh was my scientific buddy," Pearson said. "We met at Cambridge when we were both studying there years ago. We've maintained friendship ever since. We co-developed that technology. That took 13 years, and three years ago we formed a company."
     
    That company is called SISCAPA Assay Technologies, Inc., and it develops tools to conduct assays of blood proteins.
     
    Pearson said the technology needs more testing before it can be used in Canada. He said he expects it to be available in Canada within two years.
     
    "We've been bleeding ourselves for several years now," Pearson said, adding friends and family also participated in the research.
     
    "We've been measuring our bio markers, and we've got good data, but you need hundreds of data points to show the precision of it."
     
    Brazilian athletes at last summer's Pan Am and Parapan Games in Toronto used the technology to assess bio markers associated with training, stress and performance.
     
    The testing on the Brazilian athletes will continue during the 2016 Summer Olympics in Brazil.

    MORE Health ARTICLES

    Viagra Doesn't Cause Skin Cancer, Shows Study

    Viagra Doesn't Cause Skin Cancer, Shows Study
    Lifestyle factors, not Viagra, put users of erectile dysfunction drugs at higher risk of melanoma, a deadly form of skin cancer, says a study.

    Viagra Doesn't Cause Skin Cancer, Shows Study

    Smoking Linked To Breast Cancer In Young Women

    Smoking Linked To Breast Cancer In Young Women
    Smoking may increase the risk of dying early in pre-menopausal women with breast cancer, a research said.

    Smoking Linked To Breast Cancer In Young Women

    Stillbirth In First Pregnancy Ups Risk On Second Time

    Stillbirth In First Pregnancy Ups Risk On Second Time
    Women who have experienced a stillbirth have up to a four-fold increased risk of stillbirth in a second pregnancy compared to those who had an initial live birth, says a new study led by an Indian-British scientist.

    Stillbirth In First Pregnancy Ups Risk On Second Time

    Early Stage Breast Cancer Patients Getting Too Many Imaging Tests: Study

    Early Stage Breast Cancer Patients Getting Too Many Imaging Tests: Study
    Guidelines say that women diagnosed with Stage 1 or Stage 2 breast cancer don't need additional MRIs or CT scans because the risk that their cancer has spread is very low.

    Early Stage Breast Cancer Patients Getting Too Many Imaging Tests: Study

    15 Per Cent Of Kids Who Have An Anaphylactic Reaction Have Delayed 2nd Reaction

    15 Per Cent Of Kids Who Have An Anaphylactic Reaction Have Delayed 2nd Reaction
    TORONTO — A new study suggests about 15 per cent of children who have a severe allergic reaction that involves anaphylaxis can actually have a second reaction hours after the first.

    15 Per Cent Of Kids Who Have An Anaphylactic Reaction Have Delayed 2nd Reaction

    Commercialisation Of Yoga: Boon Or Bane?

    Commercialisation Of Yoga: Boon Or Bane?
    While commercialisation has surged the popularity of yoga, glamourising it to suit modern taste, this has also taken away the authenticity of the age-old discipline, say experts.

    Commercialisation Of Yoga: Boon Or Bane?